We develop and apply our methodology in collaboration with outstanding experimental colleagues including:

• Omer Bayraktar, Wellcome Sanger Institute, UK
• Elia Benito-Gutierrez, Department of Zoology, University of Cambridge, UK
• James Briscoe, The Francis Crick Institute, London, UK 
• Long Cai, Caltech, USA
• Bertie Gottgens, WT-MRC Stem Cell Institute, University of Cambridge, UK
• Gillian Griffiths, Cambridge Institute for Medical Research, University of Cambridge, UK
• Tim Halim, CRUK Cambridge Institute, University of Cambridge, UK
• Greg Hannon, CRUK Cambridge Institute, University of Cambridge, UK
• Neil Henderson, University of Edinburgh, UK
• Walid Khaled, Department of Pharmacology, University of Cambridge, UK 
• Jenny Nichols, WT-MRC Stem Cell Institute, University of Cambridge, UK
• Emma Rawlins, The Gurdon Institute, University of Cambridge, UK
• Wolf Reik, The Babraham Institute, Cambridge, UK 
• Ben Simons, The Gurdon Institute, University of Cambridge, UK
• Shankar Srinivas, University of Oxford, UK
• Oliver Stegle, DKFZ, Heidelberg, Germany
• Sarah Teichmann, Wellcome Sanger Institute, UK
• Fabian Theis, Helmholtz Zentrum München, Germany

In addition to developing computational tools and applying them via direct local and international collaborations, we also actively participate in large-scale international consortia that aim to use single-cell genomics technologies to redefine our understanding of cell types across the human body and how these can be used to better interrogate disease.

With thanks to our funders:

• Chan Zuckerberg Initiative
• CRUK
• EMBL
• Medical Research Council
• NIH
• Wellcome Trust